ArticleOpen forum infectious diseases2021

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant

Sara Alosaimy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.